Skip to main content Accessibility help
×
Home
Hostname: page-component-684899dbb8-nlvjk Total loading time: 0.812 Render date: 2022-05-19T05:15:41.582Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

25 - Hypothyroxinaemia in preterm infants

Published online by Cambridge University Press:  15 February 2010

Amanda Ogilvy-Stuart
Affiliation:
University of Cambridge
Paula Midgley
Affiliation:
University of Edinburgh
Get access

Summary

Clinical presentation

Usually incidental finding of hypothyroxinaemia in preterm baby when thyroid function assessed. In the UK, most of Europe and areas of the USA, thyroid-stimulating hormone (TSH) rather than thyroxine (T4) is measured as newborn screen for congenital hypothyroidism and hence hypothyroxinaemia without elevated TSH will not be picked up. Thyroid function may be assessed if there is a clinical suspicion of hypothyroidism, but more usually as part of a screen for prolonged jaundice.

Approach to the problem

Exclude primary hypothyroidism (elevated TSH, see Chapter 24) and central hypothyroidism (normal or low TSH, see Chapter 7).

Differential diagnosis

Hypopituitarism.

Investigations

  • fT4 and TSH.

  • Review blood sugar measurements and electrolytes and if necessary exclude hypopituitarism (see Chapter 7).

Management

Immediate

Although there is an association of low T4 levels, and morbidity and mortality in preterm babies, the data to date do not support thyroid hormone supplementation. Although one study has shown a possible benefit of thyroid hormone supplementation on the neurodevelopment of babies born between 25 and 26 weeks gestation, it also demonstrated a possible detrimental effect of thyroid hormone supplementation on neurodevelopment in babies born between 27 and 29 weeks gestation. Until further data are available, thyroid hormone supplementation in preterm babies either to prevent or to treat hypothyroxinaemia cannot be recommended outwith the context of a clinical trial.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×